Aránzazu Mediero Selected Research

Glucosamine (Dona)

1/2017

The combined therapy with chondroitin sulfate plus glucosamine sulfate or chondroitin sulfate plus glucosamine hydrochloride does not improve joint damage in an experimental model of knee osteoarthritis in rabbits.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aránzazu Mediero Research Topics

Disease

8	Inflammation (Inflammations) 11/2022 - 05/2012
6	Osteolysis 10/2021 - 05/2012
3	Osteoarthritis 11/2022 - 01/2017
3	Bone Resorption 01/2019 - 02/2012
3	Diabetic Retinopathy (Retinopathy, Diabetic) 03/2005 - 01/2004
2	Knee Osteoarthritis 11/2022 - 01/2017
2	Rheumatoid Arthritis 12/2021 - 07/2013
2	Neoplasms (Cancer) 01/2016 - 02/2013
2	Glaucoma 05/2009 - 01/2004
2	Eye Diseases (Eye Disease) 01/2004 - 04/2003
1	Synovitis 11/2022
1	Ellis-Van Creveld Syndrome (Chondroectodermal Dysplasia) 01/2022
1	Hypertrophy 01/2022
1	Joint Diseases (Joint Disease) 12/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 06/2021
1	Infections 07/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Obesity 01/2020
1	Body Weight (Weight, Body) 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 11/2016
1	Arthritis (Polyarthritis) 11/2016
1	Colonic Neoplasms (Colon Cancer) 01/2016
1	Hyperplasia 01/2016
1	Radiation Fibrosis Syndrome (Radiation Fibrosis) 01/2016
1	Fibrosis (Cirrhosis) 02/2014
1	Cicatrix (Scar) 12/2013
1	Fatigue 02/2013
1	Necrosis 02/2013
1	Prosthesis Failure 05/2012
1	Hypoxia (Hypoxemia) 02/2012
1	Wounds and Injuries (Trauma) 06/2009
1	Ocular Hypertension (Glaucoma, Suspect) 05/2009
1	Retinal Detachment (Retinal Detachments) 07/2005
1	Epiretinal Membrane (Epiretinal Membranes) 07/2004

Drug/Important Bio-Agent (IBA)

10	Adenosine (Adenocard)FDA LinkGeneric 10/2021 - 02/2012
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2009
5	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2019 - 05/2012
3	Pharmaceutical PreparationsIBA 11/2022 - 02/2013
3	Tenofovir (Viread)FDA Link 10/2021 - 01/2019
3	CollagenIBA 01/2016 - 12/2013
2	LigandsIBA 11/2022 - 02/2012
2	2- (4- (2- carboxyethyl)phenethylamino)- 5'- N- ethylcarboxamidoadenosineIBA 01/2018 - 05/2012
2	Netrin-1IBA 11/2016 - 01/2016
2	Monoclonal AntibodiesIBA 11/2016 - 01/2016
2	Methotrexate (Mexate)FDA LinkGeneric 03/2015 - 02/2013
2	Small Interfering RNA (siRNA)IBA 06/2009 - 05/2009
2	Atrial Natriuretic Factor (ANF)IBA 03/2005 - 07/2004
2	Natriuretic PeptidesIBA 03/2005 - 01/2004
2	ParaffinIBA 01/2004 - 04/2003
1	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2022
1	shogaolIBA 11/2022
1	Tamoxifen FDA LinkGeneric 01/2022
1	ConnexinsIBA 12/2021
1	Adenosine Triphosphate (ATP)IBA 12/2021
1	Antiviral Agents (Antivirals)IBA 10/2021
1	Polymethyl Methacrylate (Sol)IBA 07/2020
1	Adenosine DeaminaseIBA 05/2020
1	EnzymesIBA 05/2020
1	Inosine FDA Link 05/2020
1	NucleosidesIBA 05/2020
1	Biomarkers (Surrogate Marker)IBA 05/2020
1	Purinergic P2 Receptors (ADP Receptor)IBA 01/2020
1	AMP-Activated Protein KinasesIBA 01/2020
1	Dipyridamole (Persantine)FDA LinkGeneric 01/2019
1	Neuropilin-1IBA 01/2018
1	CD100 antigenIBA 01/2018
1	Semaphorin-3AIBA 01/2018
1	Chondroitin Sulfates (Chondroitin Sulfate)IBA 01/2017
1	Sulfates (Sulfates, Inorganic)IBA 01/2017
1	Glucosamine (Dona)IBA 01/2017
1	Laminin (Merosin)IBA 11/2016
1	AntibodiesIBA 11/2016
1	Polyethylene (Polythene)IBA 01/2016
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 09/2015
1	Phosphodiesterase 4 InhibitorsIBA 09/2015
1	apremilastIBA 09/2015
1	ZM 241385 (ZM241385)IBA 03/2015
1	CLOCK ProteinsIBA 02/2013
1	Cathepsin KIBA 05/2012
1	RANK LigandIBA 05/2012
1	OsteopontinIBA 05/2012
1	Tartrate-Resistant Acid PhosphataseIBA 02/2012
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 02/2012
1	diadenosine tetraphosphateIBA 06/2009
1	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 05/2009
1	NucleotidesIBA 05/2009
1	ParasympathomimeticsIBA 05/2009
1	Adrenergic Antagonists (Antiadrenergic Agents)IBA 05/2009
1	Peptides (Polypeptides)IBA 03/2005
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2004

Therapy/Procedure

2	Therapeutics 06/2021 - 01/2017
2	Arthroplasty 07/2020 - 03/2015
1	Intraperitoneal Injections 11/2016
1	Prosthesis Implantation 01/2016
1	Radiotherapy 01/2016
1	Prostheses and Implants (Prosthesis) 01/2016
1	Ligation 03/2015
1	Reoperation 05/2012
1	Aftercare (After-Treatment) 05/2012
1	Vitrectomy 07/2005